InterCure Ltd. (NASDAQ:INCR) (TSX:INCR) (TASE: INCR) and Clever Leaves Holdings Inc. (NASDAQ:CLVR) (NASDAQ:CLVRW) have entered into an exclusive multi-year cultivation, marketing and distribution agreement.
Over the term of the agreement, InterCure will have access to Clever Leaves’ high-THC medical cannabis flower to serve several medical cannabis markets, including the Israeli market. As part of the partnership, Clever Leaves will cultivate InterCure's strains to launch InterCure's EU-GMP compliant branded products within the EU, UK and South American markets.
